Today's NYT Strands puzzle might look simple at first glance, but don't be fooled, as it's full of sneaky connections and ...

The last time we did comparative tests of AI models from OpenAI and Google at Ars was in late 2023, when Google’s offering ...

Novo Nordisk’s GLP-1 agonist Ozempic has shown efficacy in yet another indication, achieving a 24% reduction in kidney disease-related events in people with type 2 diabetes and chronic kidney disease ...